DOYLESTOWN, PA--(MARKET WIRE)--Sep 4, 2007 -- QuantRx® Biomedical Corporation (OTC BB:QTXB.OB - News), an emerging leader in the research and development of medical diagnostic platforms and products, is pleased to announce it has entered into a long-term agreement with Kang Na Hsiung (KNH) of Taiwan, covering the process development, manufacturing, and packaging of its PAD-based product line.
